Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.

@article{Uriel2017HemocompatibilityRelatedOI,
  title={Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.},
  author={Nir Uriel and Paolo Colombo and Joseph Cleveland and James W Long and Christopher Salerno and Daniel J. Goldstein and Chetan B. Patel and Gregory A. Ewald and Antone J. Tatooles and Scott C. Silvestry and Romana John and Christiano Castello Branco Caldeira and Valluvan Jeevanandam and A. R. Boyle and Kartik Sundareswaran and Poornima R Sood and Mandeep R Mehra},
  journal={Circulation},
  year={2017},
  volume={135 21},
  pages={2003-2012}
}
BACKGROUND The HeartMate 3 (HM3) Left Ventricular Assist System (LVAS) (Abbott) is a centrifugal, fully magnetically levitated, continuous-flow blood pump engineered to enhance hemocompatibility and reduce shear stress on blood components. The MOMENTUM 3 trial (Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3) compares the HM3 LVAS with the HeartMate II (HMII) LVAS (Abbott) in advanced heart failure refractory to medical… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2018
View 5 Excerpts
Highly Influenced

Advancing ventricular assist device technology: One size fits all, but age still matters.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2018

Cardiac surgery 2017 reviewed

Clinical Research in Cardiology • 2018

Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2018
View 3 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Gregoric by gest on A ril

JG Rogers, FD Pagani, +7 authors AS Anderson
D ow nladed from Uriel et al April 25, • 2017
View 4 Excerpts
Highly Influenced

Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2017
View 1 Excerpt

Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2016

Similar Papers

Loading similar papers…